Evidence map›Paper›PMID 29327488›Full record

ArticleStem cells (Dayton, Ohio)2018

Isolation of Human Photoreceptor Precursors via a Cell Surface Marker Panel from Stem Cell-Derived Retinal Organoids and Fetal Retinae.

Jörn Lakowski, Emily Welby, Dimitri Budinger, Fabiana Di Marco, Valentina Di Foggia, James W B Bainbridge, Kyle Wallace, David M Gamm, Robin R Ali, Jane C Sowden

Abstract read
In one paragraph

Article in Stem cells (Dayton, Ohio), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Atrophic Macular Degeneration and Stem Cell Therapy: A Clinical Review.Advances in experimental medicine and biology · 2025
    Review
  13. Potential Use of Organoids in Regenerative Medicine.Tissue engineering and regenerative medicine · 2024
    Review
  14. Review
  15. Review
  16. A highly reproducible and efficient method for retinal organoid differentiation from human pluripotent stem cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  17. Review
  18. Article
  19. Evaluation of mesenchymal stem cells as anFrontiers in cell and developmental biology · 2024
    Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jörn LakowskiStem Cells and Regenerative Medicine Section, University College London, London, United Kingdom.ORCID 0000-0003-4214-7580
Emily WelbyStem Cells and Regenerative Medicine Section, University College London, London, United Kingdom.
Dimitri BudingerStem Cells and Regenerative Medicine Section, University College London, London, United Kingdom.
Fabiana Di MarcoStem Cells and Regenerative Medicine Section, University College London, London, United Kingdom.
Valentina Di FoggiaStem Cells and Regenerative Medicine Section, University College London, London, United Kingdom.
James W B BainbridgeDepartment of Genetics, UCL Institute of Ophthalmology, London, United Kingdom.
Kyle WallaceWaisman Center, University of Wisconsin-Madison School of Medicine and Public Health, Waisman Center Rm T609, Madison, Wisconsin, USA.
David M GammWaisman Center, University of Wisconsin-Madison School of Medicine and Public Health, Waisman Center Rm T609, Madison, Wisconsin, USA.ORCID 0000-0002-8152-613X
Robin R AliDepartment of Genetics, UCL Institute of Ophthalmology, London, United Kingdom.ORCID 0000-0003-3126-6517
Jane C SowdenStem Cells and Regenerative Medicine Section, University College London, London, United Kingdom.

Funding

Mechanisms of Retinogenesis in Human Stem CellsR01EY021218 · NEI · UNIVERSITY OF WISCONSIN-MADISON · PI GAMM, DAVID M · 2010 to 2017
$2.2M
Department of Health NIHR-RP-011-003Medical Research Council G0700089Medical Research Council G0901550Medical Research Council MR/J004553/1Medical Research Council MR/L012758/1Medical Research Council MR/M007871/1Medical Research Council MR/M015688/1NEI NIH HHS R01 EY021218Wellcome Trust
6 · The paper itself

Abstract

Loss of photoreceptor cells due to retinal degeneration is one of the main causes of blindness in the developed world. Although there is currently no effective treatment, cell replacement therapy using stem-cell-derived photoreceptor cells may be a feasible future treatment option. In order to ensure safety and efficacy of this approach, robust cell isolation and purification protocols must be developed. To this end, we previously developed a biomarker panel for the isolation of mouse photoreceptor precursors from the developing mouse retina and mouse embryonic stem cell cultures. In the current study we applied this approach to the human pluripotent stem cell (hPSC) system, and identified novel biomarker combinations that can be leveraged for the isolation of human photoreceptors. Human retinal samples and hPSC-derived retinal organoid cultures were screened against 242 human monoclonal antibodies using a high through-put flow cytometry approach. We identified 46 biomarkers with significant expression levels in the human retina and hPSC differentiation cultures. Human retinal cell samples, either from fetal tissue or derived from embryonic and induced pluripotent stem cell cultures, were fluorescence-activated cell sorted (FACS) using selected candidate biomarkers that showed expression in discrete cell populations. Enrichment for photoreceptors and exclusion of mitotically active cells was demonstrated by immunocytochemical analysis with photoreceptor-specific antibodies and Ki-67. We established a biomarker combination, which enables the robust purification of viable human photoreceptors from both human retinae and hPSC-derived organoid cultures. Stem Cells 2018;36:709-722.

Indexed as

AnimalsBiomarkersCell DifferentiationHumansInduced Pluripotent Stem CellsMiceMouse Embryonic Stem CellsPhotoreceptor CellsPhotoreceptor Cells, VertebratePluripotent Stem CellsRetinal DegenerationStem Cell TransplantationBiomarkersCell surface markersEmbryonic stem cellsInduced pluripotent stem cellsRetinaRetinal photoreceptorsStem cell culture

Identifiers

PMID29327488
PMCPMC5947711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.